AWA
ELV icon

Arete Wealth Advisors’s Elevance Health ELV Stock Holding History

Arete Wealth Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-625
Closed -$202K – 471
2025
Q3 		$202K Buy
625
+27
+5% +$8.4K 0.01% 727
2025
Q2 		$233K Sell
598
-564
-49% -$227K 0.02% 645
2025
Q1 		$505K Buy
1,162
+336
+41% +$135K 0.04% 391
2024
Q4 		$305K Buy
826
+69
+9% +$28.9K 0.02% 551
2024
Q3 		$393K Sell
757
-557
-42% -$298K 0.03% 437
2024
Q2 		$711K Buy
+1,314
New +$695K 0.06% 310
2024
Q1 		– Sell
-968
Closed -$457K – 467
2023
Q4 		$457K Buy
968
+132
+16% +$61K 0.03% 421
2023
Q3 		$364K Buy
836
+250
+43% +$113K 0.06% 303
2023
Q2 		$260K Sell
586
-147
-20% -$67.8K 0.02% 524
2023
Q1 		$337K Buy
733
+1
+0.1% +$476 0.03% 445
2022
Q4 		$375K Sell
732
-263
-26% -$134K 0.03% 396
2022
Q3 		$452K Buy
995
+297
+43% +$142K 0.04% 318
2022
Q2 		$337K Sell
698
-111
-14% -$54.9K 0.03% 313
2022
Q1 		$397K Buy
+809
New +$370K 0.03% 334

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Arete Wealth Advisors's ELV Position: Q4 2025 in Review

Arete Wealth Advisors sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 625 shares — an estimated $202K sold.

Arete Wealth Advisors first reported a position in ELV in Q1 2022 and held it in 14 quarters. The position peaked at $711K in Q2 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Arete Wealth Advisors reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Arete Wealth Advisors sold 625 Elevance Health shares in Q4 2025, an estimated $202K.
  • Arete Wealth Advisors first reported a position in Elevance Health in Q1 2022 and held it in 14 quarters.
  • Arete Wealth Advisors's Elevance Health position peaked at $711K in Q2 2024.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Arete Wealth Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.